{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:44Z","timestamp":1707525164307},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,13]]},"DOI":"10.7759\/cureus.43428","type":"journal-article","created":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T17:00:50Z","timestamp":1691946050000},"source":"Crossref","is-referenced-by-count":0,"title":["A Patient With Miller Fisher Syndrome With Positive GQ1b and Aquaporin-4 Antibodies: Will There Be an Aquaporin-4 Antibody Associated Disorder?"],"prefix":"10.7759","author":[{"given":"Fatin","family":"Aylia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karn","family":"Johri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riley","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehron","family":"Deriss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Eskenazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio K","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.12.002","article-title":"Neuromyelitis optica spectrum disorder: pathogenesis, treatment, and experimental models","volume":"27","author":"Wu Y","year":"2019","unstructured":"Wu Y, Zhong L, Geng J. Neuromyelitis optica spectrum disorder: pathogenesis, treatment, and experimental models. Mult Scler Relat Disord. 2019, 27:412-8. 10.1016\/j.msard.2018.12.002","journal-title":"Mult Scler Relat Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00011.2013","article-title":"Physiological roles of aquaporin-4 in brain","volume":"93","author":"Nagelhus EA","year":"2013","unstructured":"Nagelhus EA, Ottersen OP. Physiological roles of aquaporin-4 in brain. Physiol Rev. 2013, 93:1543-62. 10.1152\/physrev.00011.2013","journal-title":"Physiol Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: clinical features, immunopathogenesis and treatment","volume":"176","author":"Jarius S","year":"2014","unstructured":"Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014, 176:149-64. 10.1111\/cei.12271","journal-title":"Clin Exp Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519837705","article-title":"MOG antibody-associated encephalomyelitis\/encephalitis","volume":"25","author":"Salama S","year":"2019","unstructured":"Salama S, Khan M, Pardo S, Izbudak I, Levy M. MOG antibody-associated encephalomyelitis\/encephalitis. Mult Scler. 2019, 25:1427-33. 10.1177\/1352458519837705","journal-title":"Mult Scler"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management","volume":"13","author":"Sechi E","year":"2022","unstructured":"Sechi E, Cacciaguerra L, Chen JJ, et al.. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol. 2022, 13:885218. 10.3389\/fneur.2022.885218","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.957361","article-title":"Serological biomarkers in autoimmune GFAP astrocytopathy","volume":"13","author":"Fu CC","year":"2022","unstructured":"Fu CC, Huang L, Xu LF, et al.. Serological biomarkers in autoimmune GFAP astrocytopathy. Front Immunol. 2022, 13:957361. 10.3389\/fimmu.2022.957361","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000611","article-title":"Update: the Miller Fisher variants of Guillain-Barr\u00e9 syndrome","volume":"30","author":"Al Othman B","year":"2019","unstructured":"Al Othman B, Raabe J, Kini A, Lee AG. Update: the Miller Fisher variants of Guillain-Barr\u00e9 syndrome. Curr Opin Ophthalmol. 2019, 30:462-6. 10.1097\/ICU.0000000000000611","journal-title":"Curr Opin Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2003.11.017","article-title":"Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination","volume":"148","author":"Nishimoto Y","year":"2004","unstructured":"Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol. 2004, 148:200-5. 10.1016\/j.jneuroim.2003.11.017","journal-title":"J Neuroimmunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36924","article-title":"Miller fisher syndrome with positive anti-gq1b\/gq1d antibodies associated with covid-19 infection: a case report","volume":"15","author":"Abu-Abaa M","year":"2023","unstructured":"Abu-Abaa M, Jumaah O, Mousa A, Aldookhi A. Miller fisher syndrome with positive anti-gq1b\/gq1d antibodies associated with covid-19 infection: a case report. Cureus. 2023, 15:e36924. 10.7759\/cureus.36924","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12424","article-title":"Miller Fisher syndrome in the COVID-19 era - a novel target antigen calls for novel treatment","volume":"13","author":"Kajani S","year":"2021","unstructured":"Kajani S, Kajani R, Huang CW, Tran T, Liu AK. Miller Fisher syndrome in the COVID-19 era - a novel target antigen calls for novel treatment. Cureus. 2021, 13:e12424. 10.7759\/cureus.12424","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000000156","article-title":"Anti-asialo-GM1 and GD1a variant of Miller Fisher variant of Guillain-Barr\u00e9 syndrome","volume":"34","author":"Morgan ML","year":"2014","unstructured":"Morgan ML, Law N, Espino Barros Palau A, Saeed U, Yalmanchili S, Lee AG. Anti-asialo-GM1 and GD1a variant of Miller Fisher variant of Guillain-Barr\u00e9 syndrome. J Neuroophthalmol. 2014, 34:377-9. 10.1097\/WNO.0000000000000156","journal-title":"J Neuroophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.08.2010.3228","article-title":"Atypical Miller Fisher syndrome associated with glutamate receptor antibodies","volume":"2011","author":"Hatano T","year":"2011","unstructured":"Hatano T, Shimada Y, Kono A, et al.. Atypical Miller Fisher syndrome associated with glutamate receptor antibodies. BMJ Case Rep. 2011, 2011:10.1136\/bcr.08.2010.3228","journal-title":"BMJ Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000001687","article-title":"Severe vision loss and optic disc edema associated with GAD-65 antibody positive Miller Fisher syndrome","author":"Yasin A","year":"2022","unstructured":"Yasin A, Dudeck L, Redick DW, Khodeiry MM, Lam BL, Jiang H. Severe vision loss and optic disc edema associated with GAD-65 antibody positive Miller Fisher syndrome. J Neuroophthalmol. 2022, 10.1097\/WNO.0000000000001687","journal-title":"J Neuroophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2020.1859502","article-title":"Ataxia and ophthalmoplegia: an atypical case of Miller Fisher syndrome (MFS) with anti-GAD antibody","volume":"132","author":"Shoraka AR","year":"2022","unstructured":"Shoraka AR, Fang X, Hamouda D, Gogia B, Li X. Ataxia and ophthalmoplegia: an atypical case of Miller Fisher syndrome (MFS) with anti-GAD antibody. Int J Neurosci. 2022, 132:994-8. 10.1080\/00207454.2020.1859502","journal-title":"Int J Neurosci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000368183","article-title":"A case of neuromyelitis optica masquerading as miller fisher syndrome","volume":"6","author":"Furutani Y","year":"2014","unstructured":"Furutani Y, Hata M, Miyamoto K, Moribata Y, Yoshimura N. A case of neuromyelitis optica masquerading as miller fisher syndrome. Case Rep Neurol. 2014, 6:226-31. 10.1159\/000368183","journal-title":"Case Rep Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.11.033","article-title":"Eye movement abnormalities in AQP4-IgG positive neuromyelitis optica spectrum disorder","volume":"384","author":"Sun H","year":"2018","unstructured":"Sun H, Cui S, Gao F, You Q, Li Y, Wang J, Zhang X. Eye movement abnormalities in AQP4-IgG positive neuromyelitis optica spectrum disorder. J Neurol Sci. 2018, 384:91-5. 10.1016\/j.jns.2017.11.033","journal-title":"J Neurol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510391690","article-title":"Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with neuromyelitis optica spectrum disorder and anti-aquaporin-4 antibody","volume":"17","author":"Shinoda K","year":"2011","unstructured":"Shinoda K, Matsushita T, Furuta K, Isobe N, Yonekawa T, Ohyagi Y, Kira J. Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with neuromyelitis optica spectrum disorder and anti-aquaporin-4 antibody. Mult Scler. 2011, 17:885-7. 10.1177\/1352458510391690","journal-title":"Mult Scler"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0719-z","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: brainstem involvement - frequency, presentation and outcome","volume":"13","author":"Jarius S","year":"2016","unstructured":"Jarius S, Kleiter I, Ruprecht K, et al.. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: brainstem involvement - frequency, presentation and outcome. J Neuroinflammation. 2016, 13:281. 10.1186\/s12974-016-0719-z","journal-title":"J Neuroinflammation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.07.008","article-title":"AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: a case report and literature review","volume":"35","author":"Tao S","year":"2019","unstructured":"Tao S, Zhang Y, Ye H, Guo D. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: a case report and literature review. Mult Scler Relat Disord. 2019, 35:185-92. 10.1016\/j.msard.2019.07.008","journal-title":"Mult Scler Relat Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102205","article-title":"Anti-MOG and anti-AQP4 positive neuromyelitis optica spectrum disorder in a patient with myasthenia gravis","volume":"44","author":"Bates M","year":"2020","unstructured":"Bates M, Chisholm J, Miller E, Avasarala J, Guduru Z. Anti-MOG and anti-AQP4 positive neuromyelitis optica spectrum disorder in a patient with myasthenia gravis. Mult Scler Relat Disord. 2020, 44:102205. 10.1016\/j.msard.2020.102205","journal-title":"Mult Scler Relat Disord"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23107","article-title":"Relationship between neuromyelitis optica spectrum disorder and Sjogren syndrome: central nervous system extraglandular disease or unrelated, co-occurring autoimmunity?","volume":"69","author":"Birnbaum J","year":"2017","unstructured":"Birnbaum J, Atri NM, Baer AN, Cimbro R, Montagne J, Casciola-Rosen L. Relationship between neuromyelitis optica spectrum disorder and Sjogren syndrome: central nervous system extraglandular disease or unrelated, co-occurring autoimmunity?. Arthritis Care Res (Hoboken). 2017, 69:1069-75. 10.1002\/acr.23107","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7750\/cureus.29379","article-title":"Overlapping autoimmune neurological syndrome: a case report of triple-positive antibody","volume":"14","author":"Bonner K","year":"202220","unstructured":"Bonner K, Nour H, Memon A. Overlapping autoimmune neurological syndrome: a case report of triple-positive antibody. Cureus. 202220, 14:29379. 10.7750\/cureus.29379","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142865-a-patient-with-miller-fisher-syndrome-with-positive-gq1b-and-aquaporin-4-antibodies-will-there-be-an-aquaporin-4-antibody-associated-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:42Z","timestamp":1707508902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142865-a-patient-with-miller-fisher-syndrome-with-positive-gq1b-and-aquaporin-4-antibodies-will-there-be-an-aquaporin-4-antibody-associated-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,13]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.43428","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,13]]}}}